Joseph Romanelli

Joseph Romanelli is a declared insider of Merck & Co., Inc., with filings sourced from SEC (Form 4). Between 2 December 2022 and 26 January 2026, the trades on record add up to 20 filings.

In open-market terms, that means 8 purchases worth €42k on one side and 5 sales worth €632k on the other. Netting one side against the other leaves €590k of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 4 share grants and 3 option exercises.

Half of the purchases are above €4,510 and half below. Across 8 purchases, this insider has always bought alone, with no colleague buying within 30 days.

The latest filing, published on 28 January 2026, reports a share grant of €517k in Merck & Co., Inc. The clock since the last published purchase (30 June 2023) now reads 1,212 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.